
Meri Beckwith discusses the challenges of drug development and the impact of Eroom's Law on the pharmaceutical industry.
The pharmaceutical industry has a dirty secret: it takes $2 billion and a decade to approve the average drug, and these numbers are getting exponentially worse. While computing power doubles every few years, drug development costs double every decade—a phenomenon called Eroom’s Law (Moore’s Law backwards). Lindus Health was founded to fix this crisis. Named after James Lind, the Royal Navy surgeon who ran the first randomized controlled trial in 1747 (discovering that citrus prevents scurvy and accidentally creating the Sicilian Mafia in the process), the London-based company is slashing clinical trial costs and timelines through better software, smarter processes, and a willingness to actually keep up with FDA guidance—which, remarkably, the industry ignores. In this first part of our conversation, we explore why pharmaceutical shelves are lined with miracle drugs gathering dust, how the NHS simultaneously possesses world-class health data while being catastrophically bad at purchasing new treatments, and what Britain could gain by becoming the world’s biotech testing ground. Tom, Calum, and Meri discuss: * Why drug development costs are doubling every decade: Eroom’s Law means…
Explore listener stats, chart rankings, contacts and more on the Anglofuturism podcast page.